Folate Receptor, Trop 2, Ovarian Cancer, and Antibody-Drug Conjugate (ADC)
Saved in:
Main Authors: | Chinmoy K. Bose, Nirban Basu |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2025-08-01
|
Series: | Indian Journal of Medical and Paediatric Oncology |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1806871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in antibody-drug conjugates as cancer therapeutics
by: Jung Yin Fong, et al.
Published: (2025-08-01) -
Therapeutic index improvement of antibody-drug conjugates
by: Hans-Peter Gerber, et al.
Published: (2023-12-01) -
Exploration of the antibody–drug conjugate clinical landscape
by: Heather Maecker, et al.
Published: (2023-12-01) -
Effect and mechanism of HER2 antibody-drug conjugate combined with anti-PD-1 antibody in mouse bladder cancer models
by: HE Shuo, et al.
Published: (2025-07-01) -
AI-driven innovation in antibody-drug conjugate design
by: Heather A. Noriega, et al.
Published: (2025-06-01)